Using Human Cytomegalovirus Glycoproteins to Prevent Graft versus Host Disease through Downregulation of Major Histocompatibility Complex Class I and Class II: A Novel Approach

Yasmeen AlSaif¹, Abdelhamid Liacini² and Rabab Al Attas^2*

¹Dhahran Ahliyya Schools, Dhahran, Saudi Arabia

²Histocompatibility and Immunogenetics Laboratory (HIL), King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia

^*Corresponding Author: Rabab Al Attas, MD, D(ABHI), D(ABMLI), Consultant, Pathologist, Immunologist and Immunogeneticist Head/Histocompatibility and Immunogenetics (HIL), Immunology Laboratories, D/Chair Pathology and Lab medicine (DPLM), King Fahad Specialist Hospital-Dammam (KFSH-D), Al Mirikibat, Dammam, Kingdom of Saudi Arabia, Tel: +966 138442222 Exn. 6737 Email: